These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 12677005
1. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR. Mol Endocrinol; 2003 Jul; 17(7):1410-24. PubMed ID: 12677005 [Abstract] [Full Text] [Related]
4. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR. Mol Endocrinol; 2005 Dec; 19(12):3045-59. PubMed ID: 16051666 [Abstract] [Full Text] [Related]
5. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats. Freitas FR, Capelo LP, O'Shea PJ, Jorgetti V, Moriscot AS, Scanlan TS, Williams GR, Zorn TM, Gouveia CH. J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824 [Abstract] [Full Text] [Related]
6. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng S. Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13209-14. PubMed ID: 11069286 [Abstract] [Full Text] [Related]
7. Thyroid hormone activates fibroblast growth factor receptor-1 in bone. Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ, Brady G, Samarut J, Chassande O, Williams GR. Mol Endocrinol; 2003 Sep 21; 17(9):1751-66. PubMed ID: 12805413 [Abstract] [Full Text] [Related]
8. Association between an R338L mutation in the thyroid hormone receptor-beta gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone. Menzaghi C, Balsamo A, Di Paola R, Gallone G, Rossi C, Tassi V, Fonzo D, De Filippis V. Thyroid; 1999 Jan 21; 9(1):1-6. PubMed ID: 10037068 [Abstract] [Full Text] [Related]
11. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? Hayashi Y, Weiss RE, Sarne DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW, Refetoff S. J Clin Endocrinol Metab; 1995 Nov 21; 80(11):3246-56. PubMed ID: 7593433 [Abstract] [Full Text] [Related]
12. Expression of the mutant thyroid hormone receptor PV in the pituitary of transgenic mice leads to weight reduction. Zhu XG, Kaneshige M, Parlow AF, Chen E, Hunziker RD, McDonald MP, Cheng SY. Thyroid; 1999 Nov 21; 9(11):1137-45. PubMed ID: 10595466 [Abstract] [Full Text] [Related]
16. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate. Furlanetto TW, Kopp P, Peccin S, Gu WX, Jameson JL. Mol Genet Metab; 2000 Nov 21; 71(3):520-6. PubMed ID: 11073720 [Abstract] [Full Text] [Related]
17. Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha. Freudenthal B, Shetty S, Butterfield NC, Logan JG, Han CR, Zhu X, Astapova I, Hollenberg AN, Cheng SY, Bassett JHD, Williams GR. Thyroid; 2019 May 21; 29(5):726-734. PubMed ID: 30760120 [Abstract] [Full Text] [Related]